Pharmacogenomics
Pharmacogenomics can play an important role in identifying responders and non-responders to medications, avoiding adverse events, and optimizing drug dose. Genetic polymorphisms in drug-metabolizing enzymes, transporters, receptors, and other drug targets have been linked to inter-individual differences in the efficacy and toxicity of many medications. Pharmacogenomics’ studies are rapidly elucidating the inherited nature of these differences in drug disposition and effects, thereby enhancing drug discovery and providing a stronger scientific basis for optimizing drug therapy on the basis of each patient's genetic constitution.
Related Conference of Pharmacogenomics
July 20-21, 2026
7th International Conference on Applied Microbiology and Infectious Diseases
London, UK
August 27-28, 2026
12th International Congress on Trauma, Critical Care and Emergency Medicine
Paris, France
September 07-08, 2026
21st International Conference on Virology, Emerging Diseases & vaccines
London, UK
November 16-17, 2026
9th International Conference on Antimicrobial and Antibacterial Agents
Tokyo, Japan
November 16-17, 2026
10th International Conference on Microbiome, Probiotics & Gut Nutrition
San Francisco, USA
